Humira has been one of the world's top selling drugs for more than two decades. But thanks to some new copycats — including one that is being sold at entrepreneur Mark Cuban's online pharmacy ...

Compare and contrast Enbrel and Humira, two injectable medications for rheumatoid arthritis (RA). If you have rheumatoid arthritis (RA), you’re all too familiar with the kind of pain and joint ...

Dosage for Humira (adalimumab) may vary based on the condition it’s being used to treat. Also, your doctor may adjust your dosage over the course of your treatment. Be sure to take the Humira ...

Humira is already facing competition from biosimilars in Europe, and will face a gang of cheaper near-copies in the US from early 2023 onwards when AbbVie’s patent protection expires.

Medically reviewed by Shadi Hamdeh, MDMedically reviewed by Shadi Hamdeh, MD Humira (adalimumab) side effects may include pain, irritation, swelling, or itching at the site of the injection ...

AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end. Credit...Nic Antaya for The New York Times Supported ...

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor. Alternatives to the world’s ...

NEW YORK, June 30 (Reuters) - At least four drugmakers are expected to launch new copycat versions of AbbVie's (ABBV.N), opens new tab top-selling rheumatoid arthritis drug, Humira, over the next ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...